ABBVIE ACQUIRES ALLERGAN IN A TRANSFORMATIVE MOVE FOR BOTH COMPANIES

Elevation Capital Value Fund: AbbVie announced it was acquiring Allergan, at a +45% premium to the closing price on 24 June 2019. This announcement adds to a history of takeovers in the Fund since its inception. Allergan was one of the largest positions in the Fund which seeks to acquire companies trading below their intrinsic value and that are out of favour or focus with many investors. Read more about the most recent takeover Elevation Capital has benefited from in our monthly mailer (released 7 July 2019) here.